Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

NUTX Nutex Health Inc. Common Stock
$91.35 -0.91% -0.85
Notify me if price changes either direction
Interactive Brokers Logotype

Buy NUTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 663.4M
Enterprise value 913.5M
Trailing PE 8.951336
Forward PE 4.6143627
PEG Ratio 4.6143627
Enterprise to EBITDA 2.211
Enterprise to revenue 1.044
Price to book MRQ 2.01794
Price to sales TTM 0.75796765

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 875.3M
EBITDA 287.5M
Diluted EPS TTM 10.48
Total Cash (MRQ) 185.6M
Current ratio (MRQ) 3.412
Operating Cash Flow (TTM) 248.1M

NUTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent NUTX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.